Results 81 to 90 of about 4,752 (116)
Ketoprofen Lysine Salt vs. Ketoprofen Acid: Assessing the Evidence for Enhanced Safety and Efficacy. [PDF]
Graziosi A+5 more
europepmc +1 more source
Racial Disparities in Anesthesia Care: A Systematic Review of Pain Management and Patient Outcomes. [PDF]
Alhaj Z+5 more
europepmc +1 more source
Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management. [PDF]
Dixit T, Vaidya A, Ravindran S.
europepmc +1 more source
Dermatitis, cellulitis, and osteomyelitis caused by <i>Aspergillus nidulans</i> in a horse with pituitary pars intermedia dysfunction. [PDF]
Waitt Wolker LH, Black A, Lee JK.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Rheumatology, 1975
During a comparative trial between enteric-coated and rectally administered phenylbutazone in patients with rheumatoid disease, one patient developed a mild hepatitis. She had recently concluded a long period of gold therapy. The natural history of phenylbutazone hepatitis is reviewed on the basis of 41 case histories, and the experience with this ...
Suzanne Alexander+2 more
openaire +3 more sources
During a comparative trial between enteric-coated and rectally administered phenylbutazone in patients with rheumatoid disease, one patient developed a mild hepatitis. She had recently concluded a long period of gold therapy. The natural history of phenylbutazone hepatitis is reviewed on the basis of 41 case histories, and the experience with this ...
Suzanne Alexander+2 more
openaire +3 more sources
Pediatrics, 1956
Phenylbutazone (Butazolidin®), introduced into clinical usage in 1952 as an antirheumatic agent in gout, rheumatoid arthritis and other periarticular diseases, has gained widespread usage among adults, and a report of its accidental ingestion by a 2-year-old infant may therefore be of interest.
openaire +2 more sources
Phenylbutazone (Butazolidin®), introduced into clinical usage in 1952 as an antirheumatic agent in gout, rheumatoid arthritis and other periarticular diseases, has gained widespread usage among adults, and a report of its accidental ingestion by a 2-year-old infant may therefore be of interest.
openaire +2 more sources
The Metabolism of Phenylbutazone in the Rat
Xenobiotica, 1974Abstract1. After administration of [14C]phenylbutazone by stomach tube to rats 1/3 of the radioactivity was excreted in the faeces and almost 2/3 in the urine over 48 h. Biliary excretion after intraperitoneal injection was slightly more than 1/3 of the dose in 24 h.2.
O. M. Bakke+2 more
openaire +3 more sources
Phenylbutazone toxicity in ponies
Veterinary Record, 1979The oral administration of phenylbutazone at a dose rate of approximately 10 mg per kg per day for seven to 14 days resulted in the development of signs of toxicity in seven of eight ponies treated. Clinical signs included anorexia, depression and abdominal oedema.
A.R. Michell, Peter Lees
openaire +5 more sources
Pattern of Phenylbutazone Degradation
Journal of Pharmaceutical Sciences, 1973Phenylbutazone and phenylbutazone-antacid formulations were examined by TLC for the presence of decomposition products. A procedure was developed for minimizing on-plate oxidation of phenylbutazone during TLC analysis, and preparative TLC was utilized for isolation of the major products of decomposition. Unequivocal identification of the major products
F. Matsui, A. Vincent, D.V.C. Awang
openaire +3 more sources